CompletedNCT02768441
Dexamphetamine Blood Levels Measured With Dried Blood Spots
About this title
Read the official source — NCT02768441Medication studyAges 25+NetherlandsAddiction
Understand this study
Who was this study for?
Listed age limits: from 25 years.
- Listed locations
- AmsterdamSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: November 1, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- The Netherlands Cancer Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- Netherlands
- Age range
- Over 25 Years
- Official registry ID
- NCT02768441
- Official title
Show the full official title
Pharmacokinetics of New Dexamphetamine Sustained Release Tablets and the Clinical Validation of Measuring Dexamphetamine in Dried Blood Spots
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Amsterdam
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Netherlands Cancer Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Dexamphetamine.
Who was this study for?
Listed age limits: from 25 years.
